Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
2018;136(Pt B):343349
It is a synthetic triple-agonist peptide engineered for metabolic receptor activation
GLP3 + Cagrilintide Blend Peptide Mechanism of Action GLP3 + Cagrilintide Blend Peptide exerts its biological effects through complementary but distinct molecular pathways that work synergistically to promote appetite suppression, enhance metabolic regulation, and improve glucose homeostasis
Duration depends on goals, hormone levels, and individual response
US$ 28.08
![KLOW [80MG] – Legionary Peptides](https://legionarypeptides.com/wp-content/uploads/2026/02/klow80_peptide-936x1024.jpg)
US$ 26.14
US$ 24.03
US$ 23.78
US$ 22.31
US$ 22.28
US$ 21.20
US$ 26.81
US$ 25.85
